The FDA is increasingly hesitant on allowing drugmakers to test their cell and gene therapy candidates in human trials, The Wall Street Journal reported Jan. 10.
Read the full post on Becker's Hospital Review - Healthcare News
FDA takes wary approach on trials with cutting-edge drugs: WSJ
